The proopiomelanocortin (pro ACTH/endorphin, POMC) peptide hormone system is of central importance in animal physiology in that it has a variety of endocrine functions as well as central nervous system functions. Because of the different functions of the POMC derived peptides, the expression of these peptide hormones is regulated in a complex fashion. In this research program, it is our aim to understand how the POMC gene is regulated in the many different cell types which express it. Specifically, we wish to examine in more detail the regulation of the POMC gene in the pituitary, building on our previous work. Using POMC cDNAs and genomic DNAs, we plan to identify at which levels (transcription, RNA processing, translation, or RNA stability) glucocorticoids, estrogens, corticotropin releasing factor, dopamine and norepinephrine act to control POMC production in the pituitary. In addition, POMC gene expression in the hypothalamus will be investigated using molecular biological methods which have been developed to deal with the extremely small number of POMC producing neurons in this tissue. using the Palkovits punch technique to isolate discrete hypothalamic regions and in situ hybridization histochemistry to study POMC mRNA in individual cells, we plan to identify those factors (steroid hormones, neurotransmitters, etc. as well as physiological stimuli such as stress) which modulate POMC mRNA levels and hopefully elucidate the mechanism of that modulation. Using similar techniques as well as organ culture the developmental pattern of POMC gene expression in the fetal rat will be studied. These studies will lead to a better understanding of how an important endocrine and neromodulatory peptide hormone system is regulated at the molecular level.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM027484-06
Application #
3151754
Study Section
Endocrinology Study Section (END)
Project Start
1980-08-01
Project End
1986-07-31
Budget Start
1985-08-01
Budget End
1986-07-31
Support Year
6
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Blum, M; McEwen, B S; Roberts, J L (1987) Transcriptional analysis of tyrosine hydroxylase gene expression in the tuberoinfundibular dopaminergic neurons of the rat arcuate nucleus after estrogen treatment. J Biol Chem 262:817-21
Pritchett, D B; Roberts, J L (1987) Dopamine regulates expression of the glandular-type kallikrein gene at the transcriptional level in the pituitary. Proc Natl Acad Sci U S A 84:5545-9
Eberwine, J H; Jonassen, J A; Evinger, M J et al. (1987) Complex transcriptional regulation by glucocorticoids and corticotropin-releasing hormone of proopiomelanocortin gene expression in rat pituitary cultures. DNA 6:483-92
Millington, W R; Blum, M; Knight, R et al. (1986) A diurnal rhythm in proopiomelanocortin messenger ribonucleic acid that varies concomitantly with the content and secretion of beta-endorphin in the intermediate lobe of the rat pituitary. Endocrinology 118:829-34
Fremeau Jr, R T; Lundblad, J R; Pritchett, D B et al. (1986) Regulation of pro-opiomelanocortin gene transcription in individual cell nuclei. Science 234:1265-9
Millington, W R; O'Donohue, T L; Chappell, M C et al. (1986) Coordinate regulation of peptide acetyltransferase activity and proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary. Endocrinology 118:2024-33
Herbert, J; Wilcox, J N; Pham, K T et al. (1986) Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology 36:900-11
Dallman, M F; Makara, G B; Roberts, J L et al. (1985) Corticotrope response to removal of releasing factors and corticosteroids in vivo. Endocrinology 117:2190-7
Wilcox, J N; Roberts, J L (1985) Estrogen decreases rat hypothalamic proopiomelanocortin messenger ribonucleic acid levels. Endocrinology 117:2392-6